<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02332486</url>
  </required_header>
  <id_info>
    <org_study_id>OLP-Metabonomics-2014</org_study_id>
    <secondary_id>81403441</secondary_id>
    <nct_id>NCT02332486</nct_id>
  </id_info>
  <brief_title>Based on Metabonomics Dryness Pathogen Type of OLP: a Dynamic Study</brief_title>
  <acronym>OLP</acronym>
  <official_title>Based on Metabonomics Dryness Pathogen Type of Oral Lichen Planus of Dynamic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heilongjiang University of Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heilongjiang University of Chinese Medicine</source>
  <brief_summary>
    <textblock>
      Due to the change of life style, the incidence of oral cavity mucous membrane disease
      increased.In this study，been done a large number of pre-clinical practice and some
      experimental studies， based on the application of metabolomics technology to ultra-high
      liquid-mass spectrometry metabolomics analyzer as the core means， The metabolism of pattern
      recognition and combination of modern analytical techniques to measure blood and urine of
      patients with OLP-specific clearance of endogenous metabolites，and after the intervention of
      moss drink endogenous metabolites in the body as a whole group of. At the same time， the use
      of flow cytometry,，ELISA， immunohistochemistry and other modern technology, research OLP
      patients using clean moss drink before and after treatment of local lesions and peripheral
      blood CD4 +，CD8 + lymphocytes，Th1 cytokines (IFN-γ， TNF-α)， Th2 cytokines (IL-4，10) the
      dynamic changes. From metabolomics， cellular immunology， inflammation mechanism perspective
      of local OLP lesions， peripheral blood and changes in endogenous metabolites in the
      process,，in-depth study of traditional Chinese medicine to drink clean moss multi-component
      multi-target treatment of this disease mechanism， is widely used in traditional Chinese
      medicine treatment of OLP provide a theoretical basis for the promotion of Chinese medicine
      Qingxian Yin in the oral mucosal disease in the application， effectively solve clinical
      practice problems.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visualanalogue scale</measure>
    <time_frame>every week of eight weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cytokines</measure>
    <time_frame>every week of eight weeks</time_frame>
    <description>IFN-γ, TNF-α, IL-4 and IL-10 of the blood cells of CD4+/CD8+ and Th1/Th2 will be tested by flow cytometry or ELISA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokines</measure>
    <time_frame>rvery week of eight weeks</time_frame>
    <description>IFN-γ, TNF-α, IL-4 and IL-10 of the lesion tissue cells of CD4+/CD8+ and Th1/Th2 will be tested by immunohistochemistry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker</measure>
    <time_frame>every week of eight weeks</time_frame>
    <description>Metabolites profiles of individual in the intervention group will be analysed by PCA、OPLS-DA or UPLC-MS.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Oral Lichen Planus</condition>
  <arm_group>
    <arm_group_label>Intervene</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>For Qingxuan Decoction there are a bag of Chinese honeylocust spine，Glehnia littoralis and Smilax china L,and two bags of Silktree albizia bark, Kadsura interior,Cortex dictamni, Lilium brownii var, Silkworm larva,Forsythia suspensa and Rhizoma polygonati preparata, and three bags of viridulumArisaema erubescens and Poria cocos Wolf. All drugs are made by Jiangyin Tianjiang company in China. Qingxuan Decoction is given two times after breakfast and dinner in 56 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blank</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>There is no intervention for people in the blank group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Qingxuan Decoction</intervention_name>
    <description>In Qingxuan Decoction, there are a bag of Chinese honeylocust spine，Glehnia littoralis and Smilax china L,and two bags of Silktree albizia bark, Kadsura interior,Cortex dictamni, Lilium brownii var, Silkworm larva,Forsythia suspensa and Rhizoma polygonati preparata, and three bags of viridulumArisaema erubescens and Poria cocos Wolf. All drugs are made by Jiangyin Tianjiang company in China.</description>
    <arm_group_label>Intervene</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with OLP .

          -  TCM syndrome of OLP patients included is dryness pathogen type.

          -  In the lesions of oral mucosa there are phanerous pearly white keratinization stripes,
             or patches, or phanerous erosion with the mucous membrane hyperemia.

          -  OLP patients may accompany oral coarse discomfort or pain, red tongue, yellow dry or
             dry fur, dry mouth, bitter taste.

        Exclusion Criteria:

          -  Patients with other established oral mucosal disease;

          -  Patients accompanied by serious systemic diseases, eg damaged liver or kidney
             functions; Or other allergic diseases, eg rheumatic disease or cancer.

          -  Patients using the antibiotic in the last one month or immunologic agents in the last
             three months.

          -  Lichenoid reaction caused by drugs or the filling with silver and amalgam.

          -  Patients with smoking or alcoholism in the last three months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yang Xu Yan, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chinese Medicine Department of Stomatology, Heilongjiang University of Chinese Medicine.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yang Xu Yan, Doctor</last_name>
    <phone>+86 0451-82193038</phone>
    <email>444125750@qq.com</email>
  </overall_contact>
  <results_reference>
    <citation>Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg. 2008 Jan;46(1):15-21. Epub 2007 Sep 5. Review.</citation>
    <PMID>17822813</PMID>
  </results_reference>
  <results_reference>
    <citation>Holmstrup P, Thorn JJ, Rindum J, Pindborg JJ. Malignant development of lichen planus-affected oral mucosa. J Oral Pathol. 1988 May;17(5):219-25.</citation>
    <PMID>3144585</PMID>
  </results_reference>
  <results_reference>
    <citation>Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, Vestita C, Rosso S, Merletti F. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol. 2004 Jan;40(1):77-83.</citation>
    <PMID>14662419</PMID>
  </results_reference>
  <results_reference>
    <citation>Chaiyarit P, Ma N, Hiraku Y, Pinlaor S, Yongvanit P, Jintakanon D, Murata M, Oikawa S, Kawanishi S. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 2005 Sep;96(9):553-9.</citation>
    <PMID>16128740</PMID>
  </results_reference>
  <results_reference>
    <citation>Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol. 2005 Jul 1;175(1):5-14.</citation>
    <PMID>15972624</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee YC. Synergistic effect of various regulatory factors in TH1/TH2 balance; immunotherapeutic approaches in asthma. Int J Biomed Sci. 2008 Mar;4(1):8-13.</citation>
    <PMID>23675060</PMID>
  </results_reference>
  <results_reference>
    <citation>Krouwels FH, van der Heijden JF, Lutter R, van Neerven RJ, Jansen HM, Out TA. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol. 1996 Apr;14(4):388-97.</citation>
    <PMID>8600944</PMID>
  </results_reference>
  <results_reference>
    <citation>Agarwal SK, Marshall GD Jr. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res. 2001 Mar;21(3):147-55.</citation>
    <PMID>11331037</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Meij EH, van der Waal I. Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003 Oct;32(9):507-12.</citation>
    <PMID>12969224</PMID>
  </results_reference>
  <results_reference>
    <citation>Mendoza L. A network model for the control of the differentiation process in Th cells. Biosystems. 2006 May;84(2):101-14. Epub 2005 Dec 28.</citation>
    <PMID>16386358</PMID>
  </results_reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2014</study_first_submitted>
  <study_first_submitted_qc>January 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2015</study_first_posted>
  <last_update_submitted>January 3, 2015</last_update_submitted>
  <last_update_submitted_qc>January 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heilongjiang University of Chinese Medicine</investigator_affiliation>
    <investigator_full_name>Yang Xuyan</investigator_full_name>
    <investigator_title>Deputy director of First Affiliated Hospital of Heilongjiang University of Chinese Medicine Department of Stomatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lichen Planus</mesh_term>
    <mesh_term>Lichen Planus, Oral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

